203 related articles for article (PubMed ID: 22249238)
1. Clinical trials for glaucoma neuroprotection are not impossible.
Quigley HA
Curr Opin Ophthalmol; 2012 Mar; 23(2):144-54. PubMed ID: 22249238
[TBL] [Abstract][Full Text] [Related]
2. Glaucoma neuroprotection: What is it? Why is it needed?
Weinreb RN
Can J Ophthalmol; 2007 Jun; 42(3):396-8. PubMed ID: 17508033
[TBL] [Abstract][Full Text] [Related]
3. Protection of retinal ganglion cells in glaucoma: Current status and future.
Shen J; Wang Y; Yao K
Exp Eye Res; 2021 Apr; 205():108506. PubMed ID: 33609512
[TBL] [Abstract][Full Text] [Related]
4. Retinal ganglion cells and neuroprotection for glaucoma.
Levin LA
Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S21-4. PubMed ID: 12852431
[TBL] [Abstract][Full Text] [Related]
5. [Neuroprotection in glaucoma].
Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I
Oftalmologia; 2010; 54(2):7-10. PubMed ID: 20827905
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection: the next breakthrough in glaucoma? Proceedings of the Third Annual Optic Nerve Rescue and Restoration Think Tank.
Chew SJ; Ritch R
J Glaucoma; 1997 Aug; 6(4):263-6. PubMed ID: 9264307
[No Abstract] [Full Text] [Related]
7. Neuroprotection in glaucoma - Is there a future role?
Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
[TBL] [Abstract][Full Text] [Related]
8. Relevance of the site of injury of glaucoma to neuroprotective strategies.
Levin LA
Surv Ophthalmol; 2001 May; 45 Suppl 3():S243-9; discussion S273-6. PubMed ID: 11377443
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection in glaucoma: recent and future directions.
Danesh-Meyer HV
Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in Optic Neuropathy.
Levin LA
Asia Pac J Ophthalmol (Phila); 2018; 7(4):246-250. PubMed ID: 30066502
[TBL] [Abstract][Full Text] [Related]
11. Is neuroprotection a viable therapy for glaucoma?
Weinreb RN; Levin LA
Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
[TBL] [Abstract][Full Text] [Related]
12. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy.
Osborne NN; Chidlow G; Wood J; Casson R
Eur J Ophthalmol; 2003 Apr; 13 Suppl 3():S19-26. PubMed ID: 12749673
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
15. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
Schwartz M; London A
Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
[TBL] [Abstract][Full Text] [Related]
16. Strategies for neuroprotection.
Girkin CA
J Glaucoma; 2001 Oct; 10(5 Suppl 1):S78-80. PubMed ID: 11890287
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection--possibilities in perspective.
Weinreb RN
Surv Ophthalmol; 2001 May; 45 Suppl 3():S241-2. PubMed ID: 11377442
[No Abstract] [Full Text] [Related]
18. Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?
Kountouras J; Zavos C; Deretzi G; Polyzos SA; Gavalas E; Tsiaousi E; Giartza-Taxidou E; Chatzopoulos D; Michael S; Tsarouchas G
Exp Eye Res; 2011 May; 92(5):436-8. PubMed ID: 21377461
[No Abstract] [Full Text] [Related]
19. Axonal loss and neuroprotection in optic neuropathies.
Levin LA
Can J Ophthalmol; 2007 Jun; 42(3):403-8. PubMed ID: 17508035
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection and regeneration in glaucoma.
Levin LA
Ophthalmol Clin North Am; 2005 Dec; 18(4):585-96, vii. PubMed ID: 16314221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
